A new research review highlighting the hidden costs of dementia suggests that traditional measures only show the ‘tip of the […]
Dementia: Insomnia and sleep medications puts a higher risk of developing the condition
Sleep disturbances are common among people with Alzheimer’s and other dementias, including changes in sleep schedule and restlessness and wandering […]
First clinical proof that genotypes determine if Alzheimer’s drugs will work: Researchers’ insights into a target that succeeded in animals but failed in humans reveal a new paradigm for screening Alzheimer’s drugs
University at Buffalo researchers have determined that a human gene present in 75 % of the population is a key […]
4 Simple Habits That Could Prevent Alzheimer’s
As is the case with a number of diseases, some people are more likely to develop Alzheimer’s than others. But […]
Scientists close in on blood test for Alzheimer’s
Scientists are closing in on a long-sought goal—a blood test to screen people for possible signs of Alzheimer’s disease and […]
New biomarker in blood can diagnose Alzheimer’s in its earliest stages
Alzheimer’s disease (AD) is the primary cause of dementia, and so far, no effective treatment can prevent, delay or stop […]
Molecular structure of one of Alzheimer’s stickier culprits
In a new study published in Proceedings of the National Academy of Sciences, researchers from the University of Colorado Denver […]
Alzheimer’s therapy passes another important test: Drug candidate PRI-002 has successfully completed Phase I of clinical research
The Alzheimer drug candidate PRI-002 has successfully completed Phase I of clinical research involving healthy volunteers. When administered daily over […]
Alzheimer’s disease is a ‘double-prion disorder,’ study shows
Two proteins central to the pathology of Alzheimer’s disease act as prions—misshapen proteins that spread through tissue like an infection […]
No cure for Alzheimer’s disease in my lifetime
Biogen recently announced that it was abandoning its late stage drug for Alzheimer’s, aducanumab, causing investors to lose billions of […]